Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

Launched by CLINAMYGATE · Feb 4, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of sutures coated with an antibacterial agent called Triclosan in reducing the risk of surgical site infections (SSI) in patients undergoing clean-contaminated wound surgeries. Clean-contaminated wounds are those that may be at some risk of infection, such as surgeries involving the digestive or respiratory tracts. The trial aims to compare the rate of infections in patients who receive stitches coated with Triclosan versus those who receive standard stitches without this coating.

To participate in the trial, individuals should be between the ages of 18 and 75 and scheduled for clean-contaminated wound surgery. However, certain patients are not eligible, including those with weakened immune systems or those undergoing treatments that suppress the immune system, as well as patients who already have an infection before surgery. If you join the trial, you will receive either the Triclosan-coated sutures or the standard sutures, and researchers will monitor you to see if the type of suture affects your chances of developing an infection. This study is currently recruiting participants, and your involvement could help improve surgical care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age: 18-75
• • clean-contaminated wound surgery
• Exclusion Criteria:
• • Patient has immunodeficiency disorder.
• • Patient receiving anti-cancer / immunosuppressive therapy.
• • Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.